Xtandi
Active substance: enzalutamide
CAPSULE · ENZALUTAMIDE 40 mg/1
United StatesActive
Marketing holder: Astellas Pharma US, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ENZALUTAMIDE · 40 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2762-7219-90ef-c8fdee461e50,01a1208c-2767-7813-8840-a53bbbcf894f,01a1208d-b65b-7764-a1e5-a4c6aa9a9bfe,01a1209b-f3ae-74c2-83ac-5b4837cea056,01a1209e-596a-7123-babe-fe24bd193cf7;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0469-1125
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0469-1125 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0469-1125 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0469-1125 · Verified 2026-10-09 · open in source